Assessment of definitive residual pituitary-adrenal function and of hydrocortisone replacement therapy 10 to 14 days after microsurgery for pituitary adenomas

Horm Metab Res. 1984 Mar;16(3):157-8. doi: 10.1055/s-2007-1014729.

Abstract

Anterior pituitary function was evaluated by a combined stimulation test 10-14 days and again 6-8 months after micro-surgery for pituitary tumors. It was found that definite residual pituitary-adrenal function could accurately be assessed already 10-14 days after operation, as judged by the subsequent testing. By this means, hydrocortisone replacement therapy necessary one year after operation could be predicted.

MeSH terms

  • Adenoma / surgery*
  • Female
  • Humans
  • Hydrocortisone / therapeutic use*
  • Male
  • Microsurgery
  • Pituitary Neoplasms / surgery*
  • Pituitary-Adrenal Function Tests
  • Pituitary-Adrenal System / physiopathology*
  • Time Factors

Substances

  • Hydrocortisone